跳至主要内容
临床试验/JPRN-UMIN000037739
JPRN-UMIN000037739招募中未知

Identification of gene polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer - SNiP-RCC

Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 200 人开始时间: 2019年8月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.non-Japanese patients 2.Patients in whom the evaluation of response rate according to RECIST ver.1.1 is not carried out within 24 weeks after the start of treatment 3.Patients who received nivolumab as first line treatment 4.Patients who co-administered with drugs for renal cancer other than nivolumab 5.Patients who are judged inappropriate for participation in this study

研究者

发起方
Graduate School of Medical Sciences, Kyushu University

相似试验